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Summary PLD-repair following single dose and fractionated irradiation was studied in vivo using five human
melanoma xenograft lines. Tumours given single graded radiation doses were excised immediately after or 24 h
after the radiation exposure for assay of cell survival in vitro. All melanoma lines showed PLD-repair after
single dose irradiation; the PLD-repair factors, i.e. the ratio of the Do values for tumours excised 24 h after
and immediately after irradiation, ranged from 1.2±0.1 to 1.4±0.1. PLD-repair following fractionated
irradiation was studied by giving tumours seven fractions of 2.0 Gy over 7 days and then, after an interval of
24 h, single graded radiation doses in the range 6-21 Gy. Cell survival was assayed in vitro immediately after
or 24 h after the last radiation exposure. The Do values as well as the surviving fractions were approximately
equal after immediate and delayed cell seeding, i.e. none of the melanoma lines showed significant PLD-repair
after fractionated irradiation. The lack ofPLD-repair after fractionated irradiation was possibly a consequence
of radiation-induced recruitment of quiescent tumour cells into the cell cycle. Consequently, PLD-repair is
probably not a major cause of failure in the radiation therapy of malignant melanoma when treated with
2.0 Gy fractions.
Fertil and Malaise (1981, 1985) have analysed published
survival curves for human tumour cell lines and they found
evidence that the cell surviving fraction at 2.0 Gy (SF2) for a
given cell type was correlated to the 95% control dose for
tumours of corresponding histology. Deacon et al. (1984)
carried out a similar analysis and demonstrated a clear rela-
tionship between the initial slope of cell survival curves and
the clinical radioresponsiveness of tumours by grouping cell
lines and tumours according to histological category. On the
other hand, Weichselbaum et al. (1982a,b) showed data sug-
gesting that differences in repair of potentially lethal damage
(PLD) among cell lines in vitro may reflect differences in
clinical radiocurability among the corresponding tumour
types. If one or both of these postulates can be verified for
individual tumours, they may lead to therapeutic strategies
involving pretreatment in vitro testing of tumour
radiocurability.
The radiation biology of human melanoma xenografts
grown in congenitally athymic mice is currently being studied
in our institute. In a previous work involving five different
lines, a significant correlation was found between the
radioresponsiveness of the melanomas in vivo (2.0 Gy frac-
tions) and the initial slope of the cell survival curves in vitro
(Rofstad & Brustad, 1987). However, the melanomas were
not so radioresponsive in vivo as the SF2-values alone
predicted, suggesting that other factors, e.g. regrowth
between fractions and/or PLD-repair, also were of impor-
tance. The purpose of the study reported here was to inves-
tigate whether the radioresponsiveness of the melanomas is
significantly influenced by PLD-repair.
Materials and methods
Mice and tumours
Female BALB/c/nu/nu/BOM mice, bred at the animal depart-
ment of our institute, were used. They were kept under
specific pathogen-free conditions.
The melanoma xenograft lines (EE, EF, GE, MF, VN)
were originally derived from lymph node metastases of
patients admitted to the Norwegian Radium Hospital.
Tumour tissue was transplanted directly into athymic mice
without previous adaptation to in vitro culture conditions.
Histologically the parent metastases were similar. They were
composed of solid trabecules and nests of relatively large
cells with hyperchromatic vesicular nuclei surrounded by
partly abundant eosinophilic cytoplasm. Areas with more
spindle-shaped cells were also seen. The cytoplasm contained
little or no melanin. Numerous mitotic figures were found.
The melanoma lines were grown serially in athymic mice
by implanting tumour fragments, approximately
2 x 2 x 2 mm in size, subcutaneously into the flanks of
recipient mice. Passages 35-60 of the melanomas were used
in the present work. The melanomas were kinetically stable
during the period the experiments were carried out, as ascer-
tained by flow cytometric measurements of DNA histograms
and measurements of volumetric growth rates. Light and
electron microscopic examinations showed that the his-
tological appearance of the xenografts was similar to that of
the metastases in the donor patients.
Irradiation
A Siemens 'Stabilipan' X-ray unit, operated at 220 kV,
19-20 mA, and with 0.5 mm Cu filtration, was used for
irradiation. The tumours were irradiated in non-anaesthetised
mice at a dose rate of 5.1 Gy min '. Hypoxic conditions were
obtained by asphyxiating the mice 15 min before irradiation.
A 15 x 15 mm hole through a 2 cm thick lead block served
as beam-defining aperture. During exposure the mice were
kept in specially made, thin-walled polymethylmethacrylate
tubes with a hole in the cranial end through which they could
breathe freely. A piston in the tail end positioned the mice
firmly in the tubes. A hole was cut in each tube through
which the tumours protruded. To ensure uniform doses
throughout the tumour volumes, the tumours were exposed
to irradiation by two opposing treatment fields through each
of which 50% of the dose was delivered.
The tumours were irradiated when they attained a volume
within the range 300-500 mm3. Callipers were used to
measure tumour volumes. Two perpendicular diameters
(length and width) were recorded, and the volumes were
calculated as V= lab2 where a and b are the longest and the
shortest diameter, respectively.
Colony assay
The fraction of surviving cells in the tumours after irradia-
tion in vivo was measured in vitro using a soft agar colony
assay similar to that developed by Courtenay and Mills
(1978). Single cell suspensions were prepared from the
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tumours using a standardised mechanical procedure; the
tumours were put into plastic bags with 20 ml culture
medium (Ham's F-12 medium with 20% fetal calf serum,
penicillin (250 mgl') and streptomycin (50 mg 11), all from
Gibco Limited, Paisley, UK), and disaggregated for 30 s with
a stomacher (Lab-Blender 80, Seward Laboratory, London,
UK). The resulting suspensions were filtered through 30Am
nylon mesh. The cell concentrations were determined using a
haemocytometer. The number of host cells in the tumours,
especially macrophages, tended to be higher after frac-
tionated than after single dose irradiation. The host cells
could usually be distinguished easily from the melanoma cells
on the basis of size. Melanoma cells having an intact and
smooth outline with a bright halo were scored as mor-
phologically intact and counted. The cell yield was calculated
as the total number of morphologically intact melanoma cells
divided by the tumour volume as measured immediately
before the first radiation exposure.
The soft agar was prepared from powdered agar (Bacto
agar, Difco, Detroit, MI, USA) and culture medium (see
above). Erythrocytes from August rats and melanoma cells
were added as described previously (Rofstad, 1981). Aliquots
of I ml of soft agar with the appropriate number of
melanoma cells were seeded in plastic tubes (Falcon 2057
tubes, Becton Dickinson, Oxnard, CA, USA). The cells were
then incubated at 37°C for 3-4 weeks (EE, EF) 4-5 weeks
(MF, VN) or 5-6 weeks (GE) in an atmosphere of 5% 02,
5% Co2 and 90% N2. Culture medium (2 ml) was added on
the top of the agar 5 days after seeding and then changed
weekly. A stereomicroscope was used to count colonies. The
dense colonies formed by the melanoma cells could be distin-
guished easily from the loose colonies formed by the mac-
rophages. Melanoma cells giving rise to colonies larger than
50 cells were scored as surviving. The plating efficiency of the
morphologically intact cells from unirradiated tumours was
10-20% (GE), 15-35% (EE, MF, VN) and 30-60% (EF).
The fraction of surviving cells in an irradiated tumour was
calculated from the mean number of colonies in four tubes
with cells from that tumour and four tubes with cells from an
unirradiated tumour, and the number of morphologically
intact cells seeded and the cell yield for the two tumours, i.e.
the surviving fractions were measured relative to the number
of clonogenic cells in the tumours immediately before the
first radiation exposure.
Data analysis
Survival curves were fitted to the data by least-squares linear
regression analysis. The analysis was based on surviving frac-
tions measured for individual tumours. Only data points at
doses judged to be beyond the shoulder region of the survival
curves (asphyxiated mice) and data points at doses
eliminating the oxic cells (air-breathing mice) were included
in the analysis.
Results
Cell survival curves for tumours given single dose irradiation
are illustrated in Figure 1 and the corresponding survival
curve parameters are presented in Table I. The D. values
differed between the melanoma lines, but were approximately
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Figure 1 Radiation survival curves for five human melanoma xenograft lines. The tumours were given single dose irradiation in
vivo in air-breathing (0, A) or in asphyxiated (x) mice and excised for assay in vitro immediately after (0, *) or 24 h after (A)
irradiation. The points represent the means of four to six individual tumours studied separately and the bars represent s.e.m. The
dashed survival curves are redrawn from a previous publication (Rofstad & Brustad, 1981) and refer to single cells irradiated under





















Table I Survival curve parameters
D. (Gy)a
Asphyxiated mice Air-breathing mice Air-breathing mice PLD-repair
Melanoma (immediate seeding) (immediate seeding) (delayedseeding) factor a
Single dose irradiation
EE 2.51 ± 0.20 2.46 ± 0.25 2.95 0.18 1.2 0.1
EF 3.52±0.19 3.64±0.22 4.66±0.30 1.3±0.1
GE 3.31 ±0.21 3.17±0.18 3.74±0.21 1.2±0.1
MF 3.13±0.19 3.15±0.27 4.16±0.26 1.3±0.1
VN 3.12 ± 0.28 3.03 0.15 4.18 0.33 1.4 0.1
Fractionated irradiation
EE 2.64 ± 0.22 2.55 + 0.38 2.88 ± 0.41 1.1 ± 0.2
EF 3.56 ± 0.20 3.61 + 0.30 3.65 ± 0.38 1.0 ± 0.1
GE 3.10 ± 0.29 3.28 0.31 2.96 0.34 0.9 0.1
MF 3.32 ± 0.31 3.21 ± 0.36 3.28 ± 0.21 1.0 0.1
VN 3.15±0.24 3.06±0.35 2.88±0.30 0.9±0.1
aMean values ± s.e.m.
equal for tumours irradiated in air-breathing and asphyxiated
mice when the tumours were excised and assayed in vitro
immediately after irradiation. On the other hand, tumours
irradiated in air-breathing mice and excised 24 h after
irradiation showed higher D. values than the tumours excised
immediately after irradiation, i.e. the melanoma lines demon-
strated PLD-repair. The PLD-repair factors, calculated as the
ratio of the Do values for tumours excised 24 h after and
immediately after irradiation in air-breathing mice, ranged
from 1.2±0.1 to 1.4±0.1 (Table I). All values were
significantly different from 1.0 (P<0.05), as ascertained by a
t test.
Figure 2 shows cell survival curves for tumours given
fractionated irradiation in vivo and then assayed in vitro. The
tumours were irradiated with seven fractions of 2.0 Gy over 7
days and then, after an interval of 24 h, with single graded
radiation doses in the range 6-21 Gy in air-breathing or in
asphyxiated mice. The tumours irradiated in air-breathing
mice were excised either immediately after or 24 h after the
last radiation exposure to study PLD-repair. Significant
PLD-repair was not observed for any of the melanoma lines
after fractionated irradiation. The Do values were approx-
imately equal for all three experimental conditions (Table I)
and the cell surviving fractions were similar for tumours
excised immediately after or 24 h after irradiation in air-
breathing mice (Figure 2).
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Figure 2 Radiation survival curves for five human melanoma xenograft lines. The tumours were irradiated in vivo in air-breathing
mice with seven fractions of 2.0 Gy over 7 days (A) and then, after an interval of 24 h, with single graded radiation doses either in
air-breathing (0, A) or in asphyxiated (-) mice. The tumours were excised for assay in vitro immediately after (A, 0, *) or 24 h
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Discussion
PLD-repair following single dose irradiation has been studied
by several research groups by maintaining cultured cells in a
quiescent phase in vitro and experimental tumours in an
imperturbed state in vivo for a few hours between the radia-
tion exposure and assay of cell survival (Bertrand & Deen,
1980; Iliakis, 1988). Human tumour cell lines have thus been
found to differ considerably in PLD-repair capacity;
melanomas, for example, seem to show a particularly high
capacity (Weichselbaum & Little, 1982; Weichselbaum, 1984).
Significant PLD-repair has also been demonstrated for
several rodent tumour lines in vivo, grown in ascitic as well as
solid forms (Bertrand & Deen, 1980; Weichselbaum & Little,
1982). Moreover, human tumour xenografts, mainly
melanomas and colon adenocarcinomas, have been found to
show PLD-repair factors in vivo which are at least as high as
those observed in rodent tumours (Guichard et al., 1984;
Rofstad, 1986).
The PLD-repair factors found after single dose irradiation
of the melanoma xenograft lines studied here were com-
parable to those reported for many other in vitro and in vivo
tumour models. Interestingly, all melanoma lines lost their
PLD-repair capacity when seven fractions of 2.0Gy were
given before the test doses. Detailed studies of PLD-repair
following fractionated irradiation in vivo have not been
reported for other experimental tumours so far. In contrast
to the present observation, tumour cells cultured in vitro have
been found to maintain their PLD-repair capacity after frac-
tionated irradiation (Weichselbaum, 1984).
Lack of PLD-repair capacity in the melanomas after frac-
tionated irradiation was possibly a consequence of radiation-
induced changes in their proliferative status. Several observa-
tions suggest that PLD-repair occurs primarily in quiescent
tumour cells. Firstly, PLD-repair in vitro is usually observed
only in proliferation-inhibited cell cultures, induced by
confluence, metabolic inhibitors, low serum concentrations or
low temperature (Weichselbaum & Little, 1982; Guichard et
al., 1984). Secondly, large solid tumours express more PLD-
repair than small ones (Hahn et al., 1974; Tubiana et al.,
1977) and old ascitic tumours more than young ones (Little
et al., 1973). Thirdly, slowly growing tumours tend to show
higher PLD-repair factors than rapidly growing tumours of
the same size (Guichard et al., 1984). Finally, PLD-repair
was not observed in the RIF-I tumour line after single dose
irradiation, a line possessing a high growth fraction and a
very low fraction of radiobiologically hypoxic cells (Rasey &
Nelson, 1983). One possible explanation why PLD-repair was
not observed after fractionated irradiation of the melanomas
may therefore be that the fractionated irradiation caused
significant recruitment of quiescent tumour cells into the cell
cycle. This hypothesis is indeed supported by experimental
data on the melanomas. Thus, flow cytometric and PLM-
studies of the cell proliferation kinetics in the EE melanoma
have shown that the cell cycle time is shortened and the
growth fraction considerably increased after single dose
irradiation (Rofstad et al., 1980). Moreover, all melanoma
lines have been found to show significant repopulation (Rof-
stad & Brustad, 1987) and extensive reoxygenation (Rofstad,
1989) during fractionated irradiation (2.0 Gy fractions).
If human melanoma xenografts are representative models
for melanomas in humans, the present data may have some
implications for the choice of strategy in clinical radiation
therapy of malignant melanoma. Firstly, malignant
melanoma is treated with large radiation doses per fraction in
many countries. The single dose data in Figure 1 may
therefore have clinical relevance, suggesting that PLD-repair
may occur and hence decrease the clinical radiorespon-
siveness of malignant melanoma when large fractional doses
are given. Secondly, the data in Figure 2 indicate that PLD-
repair does not have a significant influence on the radiores-
ponsiveness of the melanoma xenografts when treated with
2.0 Gy fractions. Moreover, previous studies have shown that
the radioresponsiveness of the xenografts (2.0 Gy fractions) is
correlated to the initial slope of the corresponding radiation
cell survival curves in vitro (Rofstad & Brustad, 1987). Thus,
in vitro predictive assays for clinical radiocurability of malig-
nant melanoma should probably be based on SF2 values
rather than PLD-repair factors when conventional fractiona-
tion regimens are prescribed. Moreover, clinical trials aimed
at studying chemical modification of radiation response
should probably involve agents that modify the shoulder of
the cell survival curve, rather than agents that inhibit PLD-
repair.
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